| Protein stability during freezing: separation of stresses and mechanisms of protein stabilization BS Bhatnagar, RH Bogner, MJ Pikal Pharmaceutical development and technology 12 (5), 505-523, 2007 | 509 | 2007 |
| Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis SB Murdande, MJ Pikal, RM Shanker, RH Bogner Journal of pharmaceutical sciences 99 (3), 1254-1264, 2010 | 427 | 2010 |
| Solventless pharmaceutical coating processes: a review S Bose, RH Bogner Pharmaceutical development and technology 12 (2), 115-131, 2007 | 256 | 2007 |
| Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems KK Qian, RH Bogner Journal of pharmaceutical sciences 101 (2), 444-463, 2012 | 248 | 2012 |
| Formation of physically stable amorphous drugs by milling with Neusilin MK Gupta, A Vanwert, RH Bogner Journal of pharmaceutical sciences 92 (3), 536-551, 2003 | 245 | 2003 |
| Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse … SB Murdande, MJ Pikal, RM Shanker, RH Bogner Pharmaceutical research 27, 2704-2714, 2010 | 230 | 2010 |
| Amorphization of indomethacin by co-grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism D Bahl, RH Bogner Pharmaceutical research 23, 2317-2325, 2006 | 187 | 2006 |
| Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules MK Gupta, YC Tseng, D Goldman, RH Bogner Pharmaceutical research 19, 1663-1672, 2002 | 181 | 2002 |
| Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent MK Gupta, D Goldman, RH Bogner, YC Tseng Pharmaceutical development and technology 6 (4), 563-572, 2001 | 181 | 2001 |
| Solubility advantage of amorphous pharmaceuticals, part 3: is maximum solubility advantage experimentally attainable and sustainable? SB Murdande, MJ Pikal, RM Shanker, RH Bogner Journal of pharmaceutical sciences 100 (10), 4349-4356, 2011 | 175 | 2011 |
| Aqueous solubility of crystalline and amorphous drugs: challenges in measurement SB Murdande, MJ Pikal, RM Shanker, RH Bogner Pharmaceutical development and technology 16 (3), 187-200, 2011 | 161 | 2011 |
| Determination of calcium salt solubility with changes in pH and PCO2, simulating varying gastrointestinal environments SL Goss, KA Lemons, JE Kerstetter, RH Bogner Journal of Pharmacy and Pharmacology 59 (11), 1485-1492, 2007 | 156 | 2007 |
| Solution-mediated phase transformation: significance during dissolution and implications for bioavailability K Greco, R Bogner Journal of pharmaceutical sciences 101 (9), 2996-3018, 2012 | 148 | 2012 |
| Study of the individual contributions of ice formation and freeze-concentration on isothermal stability of lactate dehydrogenase during freezing BS Bhatnagar, MJ Pikal, RH Bogner Journal of pharmaceutical sciences 97 (2), 798-814, 2008 | 137 | 2008 |
| Fast Dissolving Tablets: New Dosage Convenience RH Bogner, MF Wilkosz US pharmacist 27 (3), 34-43, 2002 | 121 | 2002 |
| Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing K Greco, R Bogner Molecular Pharmaceutics 7 (5), 1406-1418, 2010 | 91 | 2010 |
| Freeze-drying process development and scale-up: scale-up of edge vial versus center vial heat transfer coefficients, Kv MJ Pikal, R Bogner, V Mudhivarthi, P Sharma, P Sane Journal of pharmaceutical sciences 105 (11), 3333-3343, 2016 | 79 | 2016 |
| Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization KK Qian, RH Bogner Journal of pharmaceutical sciences 100 (7), 2801-2815, 2011 | 79 | 2011 |
| The effect of annealing on the stability of amorphous solids: Chemical stability of freeze-dried moxalactam AM Abdul-Fattah, KM Dellerman, RH Bogner, MJ Pikal Journal of pharmaceutical sciences 96 (5), 1237-1250, 2007 | 78 | 2007 |
| Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding D Bahl, J Hudak, RH Bogner Pharmaceutical development and technology 13 (3), 255-269, 2008 | 69 | 2008 |
Bodhisattwa ChaudhuriProfessor, University of ConnecticutVerified email at uconn.edu
